Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Investing Activities ₹-477 Cr₹-434 Cr₹-1,339 Cr₹-1,812 Cr₹-4,480 Cr

What is the latest Cash Flow from Investing Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Investing Activities ratio of PIRAMAL PHARMA is ₹-477 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Investing Activities
Mar2025₹-477 Cr
Mar2024₹-434 Cr
Mar2023₹-1,339 Cr
Mar2022₹-1,812 Cr
Mar2021₹-4,480 Cr

How is Cash Flow from Investing Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2025 ₹-477 Cr
Negative
Mar2024 ₹-434 Cr
Negative
Mar2023 ₹-1,339 Cr
Negative
Mar2022 ₹-1,812 Cr
Negative
Mar2021 ₹-4,480 Cr -

Compare Cash Flow from Investing Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,632.7 Cr 1.8% 5.3% -17.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,054.0 Cr 0.6% 7% 1.4% Stock Analytics
DIVIS LABORATORIES ₹167,075.0 Cr 1.6% 4.6% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,904.0 Cr 3.1% 5.9% 39% Stock Analytics
CIPLA ₹107,358.0 Cr 1.5% -2.1% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,813.0 Cr 0.5% 9.8% 5.7% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

1.8%

5.3%

-17.7%

SENSEX

-1.4%

0.4%

8.3%


You may also like the below Video Courses